HIV Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2006-11-15
FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.
FDA approval · 2006-10-25
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
FDA approval · 2006-10-25
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. This action confirms regulatory approv…
FDA approval · 2006-10-16
FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
FDA approval · 2006-08-11
FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Aptivus (tipranavir) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
FDA approval · 2006-08-11
FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for ZIAGEN (abacavir sulfate) submitted by ViiV Healthcare Company, updating the drug's labeling…
FDA approval · 2006-07-10
FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.
FDA approval · 2006-07-05
FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir and ritonavir) from AbbVie, authorizing changes to its labeling.
FDA approval · 2006-06-27
FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for COMBIVIR (lamivudine and zidovudine) submitted by ViiV Healthcare Company.
FDA approval · 2006-06-23
FDA Approved: PREZISTA — Original Application (Janssen Products LP)
The FDA approves Prezista (darunavir) under an original application by Janssen Products LP for the treatment of HIV-1 infection; this marks …
FDA approval · 2006-06-13
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company. This action represents a supplemental …
FDA approval · 2006-06-13
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. Lamivudine is used to treat HIV-1 infe…
FDA approval · 2006-05-10
FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Retrovir (zidovudine) submitted by ViiV Healthcare Company.